tirzepatide and stroke Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis UC Irvine researchers project cardiac

Rapid muscle loss during Retatrutide treatment can compromise functional capacity, especially in older adults

A clinical trial by Meissner and colleagues with the GLP-1 lixisenatide demonstrated a modest reduction in motor disability progression in patients with early-stage PD

This method delivers the peptide directly where its needed , speeding up the healing process

Trial SURPASS-1 (Lancet 2021) Population 478 adults with T2D, monotherapy vs placebo

Exenatide is likely to lead with 24.4% share of the drug segment in 2025 as diabetes and obesity use cases widen across prescription channels

Chen A, Chen Z, Xia Y, Lu D, Yang X, Sun A, Zou Y, Qian J, Ge J